Moderna, Inc.
MRNA
$27.12
$0.903.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.50% | 17.36% | -616.13% | 100.36% | 7.32% |
| Total Depreciation and Amortization | 39.02% | 8.33% | -70.30% | -79.12% | -55.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.73% | 17.78% | 116.93% | -93.87% | 154.73% |
| Change in Net Operating Assets | -103.42% | -451.67% | 61.28% | -1,050.00% | -125.44% |
| Cash from Operations | 27.86% | -4.85% | 32.64% | 2.13% | -39.23% |
| Capital Expenditure | 98.35% | 40.31% | -137.27% | -7.86% | 22.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.03% | 169.75% | 94.65% | -6.14% | -15.93% |
| Cash from Investing | -65.80% | 518.64% | -0.19% | -8.62% | -15.17% |
| Total Debt Issued | -300.00% | -- | -- | -- | -- |
| Total Debt Repaid | -400.00% | -- | 91.94% | -- | 101.79% |
| Issuance of Common Stock | -56.25% | -80.00% | -26.67% | 14.29% | 100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.53% | -71.43% | 97.25% | 118.97% | 105.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.35% | 64.64% | 1,228.00% | 4.14% | 13.30% |